Sure, absolutely. As Doug was saying kind of in his comments, we’re -- the way we look at all of our direct costs, whether it’s benefits or workers’ compensation or employment practices, other types of things that are in that direct cost, it’s not just a cost picture, it’s a cost and price picture. And we’re managing that to earn a management fee on managing all the cost in that area. And so, on the benefit side, this year, we kind of expected higher costs and a wider range in our expectation because of the moving parts related to COVID treatment and it has come out just slightly above even the high end of our original range. But, as the year developed, we can move that range up. And so, we’ve been tracking that well. And of course, we’ve continued to move our pricing up, because remember, that’s the other side of the equation. So, in Doug’s remarks, he talked about the short-term period volatility, but looking more at the longer term and making sure that’s balanced over time. And this year, we had some benefit costs at the high end, but we had some other costs at the lower end. And we still ended up -- have ended up so far considerably above our original gross profit expectation. Keep in mind, Mark, that’s kind of how we go after every year. We always start with a more conservative view of the year and allow the work what we do to manage those costs, create some benefit as the year goes on. Now, on the other side of your question, what will happen with benefit cost as time rolls forward, we’ve seen basically COVID-related costs, whether it’s treatment cost, vaccinations, testing cost, it’s run about 4% of the total benefit cost over the -- each quarter. And so, that’s what’s got to kind of get built in to the ongoing trend, if the utilization normalizes up to its pre-COVID levels. And so, there’s -- the lower utilization has been offsetting some of those costs for these prior periods. And we believe we’re on track the way we’ve continued to move pricing. So, we won’t be seeing as much of a step-up in price as maybe they’ll be seeing in the marketplace. And as you kind of inferred there, that could also be a driver of new business toward us. And we consider that to be a very important part of what we do for our customers, which is to bring some level -- more level of stability to the cost increases related to health care over time. And that’s what we’ve done for many, many years through a lot of different situations that have impacted the health care market. So, I think that will also play well if in fact health care cost increase next year, the year after in the marketplace.